The emerging treatment of this peptide represents a major advance in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide affects dual pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide976176.arwebo.com/64586825/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment